The Evolution of Nuclear Medicine and the Musculoskeletal System

Radiologic Clinics of North America

Volumn 47, Issue 3, 2009, Pages 505-532

  Palestro, Christopher J ^a,b   Love, Charito ^b   Schneider, Robert ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Northwell Health   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Bone scanning; FDG PET; Gallium; Labeled leukocytes; Osteomyelitis; Trauma; Tumor

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; MEDRONATE TECHNETIUM TC 99M; PHOSPHORUS 32; STRONTIUM 85; STRONTIUM 89; TECHNETIUM 99M;

ANKLE FRACTURE; AUTORADIOGRAPHY; AVASCULAR NECROSIS; BONE METASTASIS; BONE NECROSIS; BREAST CARCINOMA; COMPLEX REGIONAL PAIN SYNDROME; COMPRESSION FRACTURE; COMPUTER ASSISTED TOMOGRAPHY; FIBROUS DYSPLASIA; HUMAN; METASTASIS; MUSCULOSKELETAL INJURY; MUSCULOSKELETAL SYSTEM; NUCLEAR MEDICINE; OSTEOID OSTEOMA; OSTEOMYELITIS; PAGET BONE DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPONDYLOLYSIS; WHOLE BODY SCINTISCANNING;

FLUORODEOXYGLUCOSE F18; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MUSCULOSKELETAL DISEASES; MUSCULOSKELETAL SYSTEM; NUCLEAR MEDICINE; POSITRON-EMISSION TOMOGRAPHY; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 63649104225     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2009.01.006     Document Type: Review

References (117)

1. Blum T. Osteomyelitis of mandible and maxilla. J Amer Dent Assoc 11 (1924) 802-805
2. Martland A.A., and Humphries R.E. Osteogenic sarcoma in dial painters using luminous paint. Arch Path 7 (1929) 406-417
3. Chiewicz O., and Hevesy G. Radioactive indicators in the study of phosphorous metabolism in rats. Nature 13 6 (1935) 754-755
4. de G Treadwell A., Low-Beer B.V.A., Fridell H.L., et al. Metabolic studies on neoplasm of bone with the aid of radioactrive strontium. Am J Med Sci 203 (1942) 521-529
5. Dudley H.C., and Maddox G.E. Deposition of radiogallium (Ga72) in skeletal tissues. J Pharmacol Exp Ther 96 (1949) 224-227
6. Bauer G.C.H., and Wendeberg B. External counting of Ca-47 and Sr-85 in studies of localized skeletal lesions in man. J Bone Joint Surg Br 41-B (1959) 558-580
7. Gynning I., Langeland P., and Lindberg S. Localization with Sr-85 of spinal metastases in mammary cancer and changes in uptake after hormone and roentgen therapy. Acta Radiol 55 (1961) 119-128
8. Cassen B., Curtis L., and Reed C. A sensitive directional gamma- ray detector. Nucleonics UCLA Report 49. Los Angeles University of California (1949)
9. Sorensen J.A., and Phelps M.E. Radionuclide imaging: other techniques and instruments. Physics in Nuclear Medicine (1980), Harcourt Brace, New York 303-327
10. Spencer H., Brothers M., Berger E., et al. Strontium-85 metabolism in man and effect of calcium on strontium excretion. Proc Soc Exp Biol Med 91 (1956) 155-157
11. Van Dilla M.A., and Arnold J.S. Strontium-85 tracer studies in humans [abstract]. Int J Appl Radiat 1 (1956) 129
12. Fleming W.H., McIlraith J.D., and King E.R. Photoscanning of bone lesions utilizing strontium-85. Radiology 77 (1961) 635-636
13. Bauer G.C.H. The use of radionuclides in orthopaedics. part IV. radionuclide scintimetry of the skeleton. J Bone Joint Surg Am 50 (1968) 1681-1709
14. Blau M., Nagler W., and Bender M.A. Fluorine-18: a new isotope for bone scanning. J Nucl Med 3 (1962) 332-334
15. Meyers W.G., and Olejar M. Radiostrontium-87m in studies of healing bone fracture [abstract]. J Nucl Med 4 (1963) 202
16. Even-Sapir E. PET/CT in malignant bone disease. Sem Musculoskeletal Radiol 11 (2007) 312-321
17. Subramanian G., and McAfee J.G. A new complex of 99mTc for skeletal imaging. Radiology 99 (1971) 192-196
18. Subramanian G., McAfee J.G., Blair R.J., et al. 99mTc-EHDP: A potential radiopharmaceutical for skeletal imaging. J Nucl Med 13 (1972) 947-950
19. Anger H.O. A new instrument for mapping gamma ray emitters. Bio Med Q Rep U Cal Res Lab 3653 (1957) 38
20. Anger H.O. Scintillation camera. Rev Sci Instrum 29 (1958) 27-33
21. Croll M.N. Nuclear medicine instrumentation. historic perspective. Semin Nucl Med 24 (1994) 3-10
22. Collier B.D., Hillman Jr. R.S., and Krasnow A.Z. Bone SPECT. Sem Nucl Med 17 (1987) 247-266
23. Bunyaviroch T., Aggarwal A., and Oates M.E. Optimized scintigraphic evaluation of infection and inflammation: role of single-photon emission computed tomography/computerized tomography fusion imaging. Sem Nucl Med 36 (2006) 295-311
24. Romer W., Nomayr A., Uder M., et al. SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients. J Nucl Med 47 (2006) 1102-1106
25. Horger M., Eschman S.M., Pfannenberg C., et al. Evaluation of combined transmission and emission tomography for classification of skeletal lesions. AJR 183 (2004) 655-661
26. Utsunomiya D., Shiraishi S., Imuta M., et al. Added value of SPECT/CT fusion in assessing suspected bone metastasis: comparison with scintigraphy alone and nonfused scintigraphy and CT. Radiology 238 (2006) 264-271
27. Even-Sapir E., Flusser G., Lerman H., et al. SPECT/multislice low-dose CT: a clinically relevant constituent in the imaging algorithm of nononcologic patients referred for bone scintigraphy. J Nucl Med 48 (2007) 319-324
28. Anger H.O. Scitillation and positron cameras. U Cal Res Lab 96 (1959) 40
29. 18F-FDG-PET. RadioGraphics 25 (2005) 1357-1368
30. Palestro C.J., Love C., and Miller T.T. Imaging of musculoskeletal infections. Best Pract Res Clin Rheumatol 20 (2006) 1197-1218
31. Van der Wall H., and Fogelman I. Scintigraphy of benign bone disease. Sem Musculoskel Radiol 11 (2007) 281-300
32. Monteleone Jr. G.P. Stress fractures in the athlete. Orthop Clin North Am 26 3 (1995) 423-432
33. Cook G.J., Hannaford E., See M., et al. The value of bone scintigraphy in the evaluation of osteoporotic patients with back pain. Scand J Rheumatol 31 (2002) 245-248
34. Versijpt J., Dierckx R.A., De Bondt P., et al. The contribution of bone scintigraphy in occupational health or medical insurance claims: a retrospective study. Eur J Nucl Med 26 (1999) 804-811
35. Jason J., Ma J.J., Kang B.K., et al. Pediatric musculoskeletal nuclear medicine. Sem Musculoskel Radiol 11 (2007) 322-334
36. Miller J.H., and Sanderson R.A. Scintigraphy of toddler's fracture. J Nucl Med 29 (1988) 2001-2003
37. Park H.M., Kernek C.B., and Robb J.A. Early scintigraphic findings of occult femoral and tibial fractures in infants. Clin Nucl Med 13 (1988) 271-275
38. Lim R., Fahey F.H., Drubach L.A., et al. Early experience with 18F sodium fluoride bone PET in young patients with back pain. J Pediatr Orthop 27 (2007) 277-282
39. Desai A., Alavi A., Dalinka M., et al. Role of bone scintigraphy in the evaluation and treatment of nonunited fractures: concise communication. J Nucl Med 21 (1980) 931-934
40. Mont M.A., and Hungerford D.S. Nontraumatic avascular necrosis of the femoral neck. J Bone Joint Surg Am 77 (1995) 459-474
41. Conway W.F., Totty W.G., and McEnery K.W. CT and MR imaging of the hip. Radiology 198 (1996) 297-307
42. Ryu J.S., Kim J.S., Moon D.H., et al. Bone SPECT is more sensitive than MRI in the detection of early osteonecrosis of the femoral head after renal transplantation. J Nucl Med 43 (2002) 1006-1011
43. Genant H.K., Kozin F., Bekerman C., et al. The reflex sympathetic dystrophy syndrome. A comprehensive analysis using fine-detail radiography, photon absorptiometry, and bone and joint scintigraphy. Radiology 117 (1975) 21-32
44. Mackinnon S.E., and Holder S.E. The use of three phase radionuclide bone scanning in the diagnosis of reflex sympathetic dystrophy. J Hand Surgery Am 9 (1984) 556-563
45. Nadel H.R., and Stilwell M.E. Nuclear medicine topics in pediatric musculoskeletal disease: techniques and applications. Radiol Clin North Am 39 (2001) 619-651
46. Fukumitsu N., Dohi M., Midda K., et al. Bone scintigraphy in polyostotic fibrous dysplasia. Clin Nucl Med 24 (1999) 446-447
47. Di Leo C., Ardemagni A., Bestetti A., et al. A rare case of polyostotic fibrous dysplasia assessed by bone scintigraphy with Tc-99m methylene diphosphonate (MDP). Nuklearmedizin 38 (1999) 169-171
48. Kanis J.A. Paget's disease of bone (osteitis deformans). In: Goldman L., and Bennett J.C. (Eds). Cecil Textbook of Medicine. 21st edition (2000), Saunders, Philadelphia 1413-1416
49. Wellman H.N., Schauwecker D., Robb J.A., et al. Skeletal scintimaging and radiography in the diagnosis and management of Paget's disease. Clin Orthop 127 (1977) 55-62
50. Love C., Din A.S., Tomas M.B., et al. Radionuclide bone imaging: an illustrative review. RadioGraphics 23 (2003) 341-358
51. Ryan P.J., and Fogelman I. Bone scintigraphy in metabolic bone disease. Semin Nucl Med 27 (1997) 291-305
52. Mari C., Catafau A., and Carrio I. Bone scintigraphy and metabolic disorders. Q J Nucl Med 43 (1999) 259-267
53. Lisbona R., and Rosenthall L. Role of radionuclide imaging in osteoid osteoma. AJR Am J Roentgenol 132 (1979) 77-80
54. Roach P.J., Connolly L.P., Zurakowski D., et al. Osteoid osteoma: comparative utility of high-resolution planar and pinhole magnification scintigraphy. Pediatr Radiol 26 (1996) 222-225
55. Dasgeb B., Mulligan M.H., and Kim C.K. The current status of bone scintigraphy in malignant diseases. Semin Musculoskelet Radiol 11 (2007) 301-311
56. Cook G.J., Houston S., Rubens R., et al. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 16 (1998) 3375-3379
57. Burgman P., Odonoghue J.A., Humm J.L., et al. Hypoxia induced increase in FDG uptake in MCF7 cells. J Nucl Med 42 (2001) 170-175
58. Nakai T., Okuyama C., Kubota T., et al. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imaging 32 (2005) 1253-1258
59. Abe K., Sasaki M., Kuwabara Y., et al. Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer. Ann Nucl Med 19 (2005) 573-579
60. Lonneux M., Borbath I., Berliere M., et al. The place of whole-body PET FDG for the diagnosis of distant recurrence of breast cancer. Clin Positron Imaging 3 (2000) 45-49
61. Fricke E., Machtens S., Hofmann M., et al. Positron emission tomography with 11C-acetate and 18F-FDGin prostate cancer patients. Eur J Nucl Med Mol Imaging 30 (2003) 607-611
62. Morris M.J., Akhurst T., Osman I., et al. Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer. Urology 59 (2002) 913-918
63. Lardinois D., Weder W., Hany T.F., et al. Staging of non-small cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348 (2003) 2500-2507
64. Cheran S.K., Herndon J.E., and Patz E.F. Comparison of wholebody FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer 44 (2004) 317-325
65. Moog F., Kotzerke J., and Reske S.N. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 40 (1999) 1407-1413
66. Durie B.G., Waxman A.D., D'Agnolo A., et al. Whole-body 18F-FDG PET identifies high-risk myeloma. J Nucl Med 43 (2002) 1457-1463
67. Schirrmeister H., Bommer M., Buck A.K., et al. Initial results in the assessment of multiple myeloma using F-18 FDG. PET. Eur J Nucl Med Mol Imaging 29 (2002) 361-366
68. Nanni C., Zamagni E., Farsad M., et al. Role of (18)F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. Eur J Nucl Med Mol Imaging 33 (2006) 525-531
69. Mahfouz T., Miceli M.H., Saghafifar F., et al. 18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. J Clin Oncol 23 (2005) 7857-7863
70. Aoki J., Watanabe H., Shinozaki T., et al. FDG PET of primary benign and malignant. bone tumors: standardized uptake value in 52 lesions. Radiology 219 (2001) 774-777
71. Folpe A.L., Lyles R.H., Sprouse J.T., et al. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 6 (2000) 1279-1287
72. Eary J.F., O'Sullivan F., Powitan Y., et al. Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis. Eur J Nucl Med Mol Imaging 29 (2002) 1149-1154
73. Tateishi U., Yamaguchi U., Seki K., et al. Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography. Eur J Nucl Med Mol Imaging 33 (2006) 683-691
74. Pezeshk P., Sadow C.A., Winalski C.S., et al. Usefulness of 18F-FDG PET-directed skeletal biopsy for metastatic neoplasm. Acad Radiol 13 (2006) 1011-1015
75. Wuisman P., and Enneking W.F. Prognosis of patients who have osteosarcoma with skip metastasis. J Bone Joint Surg Am 72 (1990) 60-68
76. Brenner W., Bohuslavizki K.H., and Eary J.F. PET imaging of osteosarcoma. J Nucl Med 44 (2003) 930-942
77. Hawkins D.S., Schuetze S.M., Butrynski J.E., et al. [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol 23 (2005) 8828-8834
78. Abdel-Dayem H.M. The role of nuclear medicine in primary bone and soft tissue tumors. Semin Nucl Med 27 (1997) 355-363
79. Sugawara Y., Fisher S.J., Zasadny K.R., et al. Preclinical and clinical studies of bone marrow uptake of fluorine-18-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol 16 (1998) 173-180
80. Clamp A., Danson S., Nguyen H., et al. Assessment of therapeutic response in patients with metastatic bone disease. Lancet Oncol 5 (2004) 607-616
81. Kazama T., Swanston N., Podoloff D.A., et al. Effect of colony-stimulating factor and conventional- or high-dose chemotherapy on FDG uptake in bone marrow. Eur J Nucl Med Mol Imaging 32 (2005) 1406-1411
82. Cook G.J., and Fogelman I. The role of positron emission tomography in skeletal disease. Semin Nucl Med 31 (2001) 50-61
83. Schirrmeister H., Guhlmann A., Kotzerke J., et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 17 (1999) 2381-2389
84. Even-Sapir E., Metser U., Flusser G., et al. Assessment of malignant skeletal disease: initial experience with 18Ffluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT. J Nucl Med 45 (2004) 272-278
85. Even-Sapir E., Metser U., Mishani E., et al. The detection of bone metastases in patients with high- risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18Ffluoride PET, and 18F-fluoride PET/CT. J Nucl Med 47 (2006) 287-297
86. McCarville M.B., Christie R., Daw N.C., et al. PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol 184 (2005) 1293-1304
87. Palestro C.J., and Love C. Radionuclide imaging of musculoskeletal infection: coventional agents. Semin Musculoskelet Radiol 11 (2007) 335-352
88. Palestro C.J., Love C., Tronco G.G., et al. Combined labeled leukocyte and technetium-99m sulfur colloid marrow imaging for diagnosing musculoskeletal infection: principles, technique, interpretation, indications and limitations. RadioGraphics 26 (2006) 859-870
89. Palestro C.J., Kim C.K., Swyer A.J., et al. Radionuclide diagnosis of vertebral osteomyelitis: indium-111-leukocyte and technetium-99m-methylene diphosphonate bone scintigraphy. J Nucl Med 32 (1991) 1861-1865
90. Whalen J.L., Brown M.L., McLeod R., et al. Limitations of indium leukocyte imaging for the diagnosis of spine infections. Spine 16 (1991) 193-197
91. Gemmel F., Dumarey N., and Palestro C.J. Radionuclide imaging of spinal infections. Eur J Nucl Med Mol Imag 33 (2006) 1226-1237
92. Love C., and Palestro C.J. 99mTc-fanolesomab. IDrugs 6 (2003) 1079-1085
93. 99mTc-labeled antigranulocyte antibodies compared with diagnosis with indium-111-labeled leukocytes-initial experience. Radiology 223 (2002) 758-764
94. Palestro C.J., Caprioli R., Love C., et al. Rapid Diagnosis of Pedal Osteomyelitis in Diabetics With a Technetium-99m Labeled Monoclonal Antigranulocyte Antibody. J Foot Ankle Surg 42 (2003) 2-8
95. 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med 47 (2006) 587-594
96. Horger M., Eschmann S.M., Pfannenberg C., et al. Added value of SPECT/CT in patients suspected of having bone infection: preliminary results. Arch Orthop Trauma Surg 127 (2007) 211-221
97. Filippi L., and Schillaci O. Tc-99m HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med 47 (2006) 1908-1913
98. Horger M., Eschmann S.M., Pfannenberg C., et al. The value of SPET/CT in chronic osteomyelitis. Eur J Nucl Med Mol Imaging 30 (2003) 1665-1673
99. Palestro CJ, Keidar Z, Love C. Infectious and inflammatory diseases. In: Delbeke D, Israel O. (Editors). Hybrid PET/CT and SPECT/CT Imaging - A Teaching File. Springer - Verlag, In press.
100. Guhlmann A., Brecht-Krauss D., Suger G., et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 206 (1998) 749-754
101. De Winter F., Van de Wiele C., Vogelaers D., et al. Flourine -18 flourodeoxyglucose-positron emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg 83-A (2001) 651-660
102. Kälicke T., Schmitz A., Risse J.H., et al. Flourine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 27 (2000) 524-528
103. Schiesser M., Stumpe K.D.M., Trentz O., et al. Detection of metallic implant-associated infections with FDG PET in patients with trauma: Correlation with microbiologic results. Radiology 226 (2003) 391-398
104. Stumpe K.D., Zanetti M., Weishaupt D., et al. FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging. Am J Roentgenol 179 (2002) 1151-1157
105. Gratz S., Dorner J., Fischer U., et al. 18F-FDG hybrid PET in patients with suspected spondylitis. Eur J Nucl Med Mol Imaging 29 (2002) 516-524
106. de Winter F., Gemmel F., Van de Wiele C., et al. 18-fluorine fluorodeoxyglucose positron emission tomography for the diagnosis of infection in the postoperative spine. Spine 28 (2003) 1314-1319
107. 18F-FDG-PET/CT. J Nucl Med 46 (2005) 444-449
108. Schwegler B., Stumpe K.D., Weishaupt D., et al. Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB. J Intern Med 263 (2008) 99-106
109. Basu S., Chryssikos T., Houseni M., et al. Potential role of FDG-PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuropathy from osteomyelitis and soft tissue infection?. Nucl Med Commun 28 (2007) 465-472
110. Hopfner S., Krolak C., Kessler S., et al. Preoperative imaging of Charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int 25 (2004) 890-895
111. 18F-FDG PET in detecting infected lower limb prosthesis implants. J Nuc Med 42 (2001) 44-48
112. Chacko T.K., Zhuang H., Stevenson K., et al. The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses. Nucl Med Commun 23 (2002) 851-855
113. 18F] fluorodeoxyglucose positron emission tomography to differentiate between synovitis, loosening and infection of hip and knee prostheses. Nucl Med Commun 23 (2002) 645-653
114. Reinartz P., Mumme T., Hermanns B., et al. Radionuclide imaging of the painful hip arthroplasty. Positron-emission tomography versus triple-phase bone scanning. J Bone Joint Surg [Br] 87 (2005) 465-470
115. Pill S.G., Parvizi J., Tang P.H., et al. Comparison of fluorodeoxyglucose positron emission tomography and (111)indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip. J Arthroplasty 21 (2006) 91-97
116. Stumpe K.D., Notzli H.P., Zanetti M., et al. FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. Radiology 231 (2004) 333-341
117. Love C., Marwin S.E., Tomas M.B., et al. Diagnosing infection in the failed joint replacement: a comparison of coincidence detection fluorine-18 FDG and indium-111-labeled leukocyte/technetium-99m-sulfur colloid marrow imaging. J Nucl Med 45 (2004) 1864-1871